Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check3 days agoChange DetectedRevision history updated: v3.5.0 was removed. v3.5.2 was added.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedHb SS disease added to related terms and Genetic and Rare Diseases Information Center added under Resources.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 has been removed.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded Revision: v3.4.2 and removed an outdated funding-status notice and an earlier revision note, representing site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded a government-funding lapse notice and updated the page revision to v3.4.1; removed the previous revision v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.